Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention-Reference-Cited by-同舟云学术

Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention

Published:2020-04-16 Issue:7 Volume:3 Page:2000034
ISSN:2366-3987
Container-title:Advanced Therapeutics
language:en
Short-container-title:Adv. Therap.

Author:

Abdulla Aynur¹,Wang Boqian¹,Qian Feng²,Kee Theodore³⁴⁵,Blasiak Agata³⁴⁵,Ong Yoong Hun³,Hooi Lissa⁶,Parekh Falgunee⁷,Soriano Rafael⁷,Olinger Gene G.⁸⁹,Keppo Jussi¹⁰,Hardesty Chris L.¹¹,Chow Edward K.³⁶¹²,Ho Dean³⁴⁵¹²^ORCID,Ding Xianting¹

Affiliation:

1. Institute for Personalized Medicine School of Biomedical Engineering Shanghai Jiao Tong University Shanghai 200030 China

2. Ministry of Education Key Laboratory of Contemporary Anthropology Human Phenome Institute School of Life Sciences Fudan University Shanghai 200438 China

3. The N.1 Institute for Health (N.1) National University of Singapore Singapore 117456 Singapore

4. The Institute for Digital Medicine (WisDM) Yong Loo Lin School of Medicine National University of Singapore Singapore 11756 Singapore

5. Department of Biomedical Engineering NUS Engineering National University of Singapore Singapore 117583 Singapore

6. Cancer Science Institute of Singapore National University of Singapore Singapore 117599 Singapore

7. EpiPointe LLC Cary NC 27518 USA

8. Global Health Surveillance and Diagnostic Division MRIGlobal Gaithersburg MD 20878 USA

9. Boston University School of Medicine Division of Infectious Diseases Boston MA 02118 USA

10. NUS Business School and Institute of Operations Research and Analytics National University of Singapore Singapore 119245 Singapore

11. KPMG Global Health and Life Sciences Centre of Excellence Singapore 048581 Singapore

12. Department of Pharmacology Yong Loo Lin School of Medicine National University of Singapore Singapore 117600 Singapore

Funder

National Basic Research Program of China

Ministry of Education - Singapore

National Medical Research Council

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry, medical,Genetics(clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adtp.202000034

Reference109 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. First Case of 2019 Novel Coronavirus in the United States

3. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

4. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

5. A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination therapy synergism prediction for virus treatment using machine learning models;PLOS ONE;2024-09-04

2. Opening a new chapter in health care: reporting on the inauguration of the International Conference on AI in Medicine;Singapore Medical Journal;2024-03

3. N-of-1 medicine;Singapore Medical Journal;2024-03

4. Piquing artificial intelligence towards drug discovery: Tools, techniques, and applications;Drug Development Research;2024-02-20

5. Drug Repurposing in the Chemotherapy of Infectious Diseases;Molecules;2024-01-29